Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report

Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report

SARS-CoV-2 virtual wards have successfully developed to monitor and escalate patients to hospital throughout the pandemic. Here we describe the case of an 84 year old man who received his complete care for severe SARS-CoV-2 pneumonitis at home, including the administration of oxygen, dexamethasone and tocilizumab.

References

  1. Recovery collaborative group. 2021. Tocilizumab in patients admitted to hospital with COVID-19 (Recovery): a randomised, controlled, open-label, platform trial. Lancet. 397: 1637-45
  2. Department of health and social care. 2021. Interim clinical commission policy: Tocilizumab for hospitalised patients with COVID-19 pneumonia (adults). Available at https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAttachment.aspx?Attachment_id=103773 Accessed 14/9/21
  3. Roche products Ltd. 2021. RoActemra solution for injection in Pre-filled syringe, summary of product characteristics. Available at https://www.medicines.org.uk/emc/product/5357/smpc#grefAccessed 21/10/21
  4. Nunan J, Clarke D, Malakouti A, Tannetta D, Calthrop A, XuX, Chan N, Khalil R, Li W, Walden A. 2020. Triage Into the Community for Covid-19 (TICC-19) Patient pathway – Service evaluation of the virtual monitoring of patients with COVID pneumonia. Acute Medicine ;19(4);183-191.
  5. Shepperd S, Butler C, Cradduck-Bamford A, Ellis G, Gray A, Hemsley A, Khanna P, Langhorne P, Mort S, Ramsay S, Schiff R, Stott D, Wilkinson A, Yu LM, Young J. 2021. Is comprehensive geriatric assessment admission avoidance hospital at home an alternative to hospital admission for older persons? A randomized trial. Annals of Internal Medicine. 174(7); 889-898.

Request Permissions

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:

Get Permission

Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report

28th March 2022
PMID: 35342912
Authors Affiliations
SE McGlen MPharm, Oxford University Hospitals NHS Foundation Trust
N Stoesser DPhil Oxford University Hospitals NHS Foundation Trust and Nuffield Department of Medicine, University of Oxford
C Woodrow MRCP, PhD Oxford Univeristy Hospitals NHS Foundation Trust and Medical Sciences Division University of Oxford
J Dudley RN, BSc Oxford University Hospitals NHS Foundation Trust
D Newton D.Sc.
D Lasserson MD FRCPEdin Oxford University Hospitals NHS Foundation Trust and Warwick Medical School, University of Warwick

Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report

Cite this article as:

McGlen SE, Stoesser N, Woodrow C, Dudley J, Newton D, Lasserson D. Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report. Acute Med. 2022;21(1):53-55. doi: 10.52964/AMJA.0894. PMID: 35342912.

Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report

Share this article

Click the icon of the social media platform on which you would like to share this article.


Shopping Basket
Scroll to Top